APA (7th ed.) Citation

M, F., I, H., MC, R., E, G., E, S., A, V., . . . Z, C. (2022). Validation of diagnostic nomograms based on CE-MS urinary biomarkers to detect clinically significant prostate cancer. World journal of urology, 40(9), 2195. https://doi.org/10.1007/s00345-022-04077-1

Chicago Style (17th ed.) Citation

M, Frantzi, et al. "Validation of Diagnostic Nomograms Based on CE-MS Urinary Biomarkers to Detect Clinically Significant Prostate Cancer." World Journal of Urology 40, no. 9 (2022): 2195. https://doi.org/10.1007/s00345-022-04077-1.

MLA (9th ed.) Citation

M, Frantzi, et al. "Validation of Diagnostic Nomograms Based on CE-MS Urinary Biomarkers to Detect Clinically Significant Prostate Cancer." World Journal of Urology, vol. 40, no. 9, 2022, p. 2195, https://doi.org/10.1007/s00345-022-04077-1.